###
中国临床研究英文版:2026,39(6):820-823,828
本文二维码信息
码上扫一扫!
糖尿病心血管自主神经病变的中西医诊治
(1.江苏大学鼓楼临床医学院内分泌科,江苏 南京 210008;2.南京大学医学院附属鼓楼医院内分泌科国家代谢性疾病临床医学研究中心分中心,江苏 南京 210008;3.南京大学医学院附属鼓楼医院中医科,江苏 南京 210008)
Diagnosis and treatment of diabetic cardiovascular autonomic neuropathy with Chinese medicine and Western medicine
(1.Endocrinology Department, Gulou Clinical Medical College, Jiangsu University, Nanjing, Jiangsu 210008, China;2.Sub-center of the National Clinical Research Center for Metabolic Diseases, Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, Jiangsu 210008;3.Department of Traditional Chinese Medicine, Gulou Hospital affiliated to Nanjing University Medical School, Nanjing, Jiangsu 210008)
摘要
本文已被:浏览 138次   下载 169
Received:July 15, 2025   Published Online:June 28, 2026
中文摘要: 糖尿病心血管自主神经病变(DCAN)是糖尿病常见的并发症之一,会显著增加各种心血管不良事件的发病风险。但DCAN起病隐匿、危害严重,目前尚缺乏有效延缓和逆转疾病进程的治疗药物。因此,对DCAN的早期防控至关重要。本文着重阐述近年来DCAN在中西医领域的诊治研究进展,为糖尿病心血管自主神经病变的早期防控、新药研发及中西医联合诊疗方案的制定提供思路。
Abstract:Diabetic cardiac autonomic neuropathy(DCAN)is one of the common complications of diabetes, significantly increasing the risk of various adverse cardiovascular events. However, DCAN has an insidious onset and severe consequences, and there are currently no effective medications to delay or reverse the progression of the disease. Therefore, early prevention and control of DCAN are crucial. This paper focuses on the recent advance in the diagnosis and treatment of DCAN in Chinese medicine and Western medicine, to provide insights for early prevention and control, new drug development, and the formulation of integrated treatment strategies combining both approaches for DCAN.
文章编号:     中图分类号:R587.2    文献标志码:A
基金项目:国家重大疑难疾病中西医临床协作项目(2024-92);江苏省中医药科技发展计划面上项目(2023061);南京市中医药青年人才培养计划(ZYQ20066);南京大学中国医院改革发展研究院面上课题(NDYGN2023004);南京大学中医研究院中西医协同研究开放课题(ICMN2024016)
引用文本:


Scan with WeChat

Scan with WeChat